Hostname: page-component-89b8bd64d-dvtzq Total loading time: 0 Render date: 2026-05-07T11:18:25.271Z Has data issue: false hasContentIssue false

Crystal structure of niraparib tosylate monohydrate Form I, (C19H21N4O)(C7H7O3S)(H2O)

Published online by Cambridge University Press:  02 May 2025

James A. Kaduk*
Affiliation:
Department of Chemistry, Illinois Institute of Technology, Chicago, IL, USA Department of Physics, North Central College, Naperville, IL, USA
Anja Dosen
Affiliation:
International Centre for Diffraction Data (ICDD), Newtown Square, PA, USA
Tom N. Blanton
Affiliation:
International Centre for Diffraction Data (ICDD), Newtown Square, PA, USA
*
Corresponding author: James A. Kaduk; Email: kaduk@polycrystallography.com

Abstract

The crystal structure of niraparib tosylate monohydrate Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Niraparib tosylate monohydrate Form I crystallizes in space group P-1 (#2) with a = 7.22060(7), b = 12.76475(20), c = 13.37488(16) Å, α = 88.7536(18), β = 88.0774(10), γ = 82.2609(6)°, V = 1,220.650(16) Å3, and Z = 2 at 298 K. The crystal structure consists of alternating double layers of cations and anions (including the water molecules) parallel to the ab-plane. Hydrogen bonds are prominent in the crystal structure. The water molecule acts as a donor to two different O atoms of the tosylate anion and as an acceptor from one of the H of the protonated piperidine ring. The other piperidyl N–H acts as a donor to the carbonyl group of another cation. Surprisingly, there are no cation–anion N–H···O hydrogen bonds. The amide group forms as a N–H···O hydrogen bond to the anion and an intramolecular N–H···N hydrogen bond to the indazole ring. The powder pattern has been submitted to the International Centre for Diffraction Data for inclusion in the Powder Diffraction File™.

Information

Type
New Diffraction Data
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of International Centre for Diffraction Data
Figure 0

Figure 1. The two-dimensional structure of niraparib tosylate monohydrate.

Figure 1

Figure 2. The Rietveld plot for the first refinement of niraparib tosylate monohydrate Form I (Rwp = 0.0537). The blue crosses represent the observed data points, and the green line is the calculated pattern. The cyan curve is the normalized error plot, and the red line is the background curve. The vertical scale has been multiplied by a factor of 3× for 2θ > 17.0̊ and by a factor of 10× for 2θ > 32.0̊.

Figure 2

Figure 3. The Rietveld plot for the second refinement of niraparib tosylate monohydrate Form I (Rwp = 0.0537). The blue crosses represent the observed data points, and the green line is the calculated pattern. The cyan curve is the normalized error plot, and the red line is the background curve. The vertical scale has been multiplied by a factor of 3× for 2θ > 17.0̊ and by a factor of 5× for 2θ > 36.0̊.

Figure 3

Figure 4. Comparison of the experimental powder pattern of niraparib tosylate monohydrate reported by Mudda et al. (2024) (black) with that calculated from their single-crystal structure (green). The literature pattern (measured using Cu Kα radiation) was digitized using UN-SCAN-IT (Silk Scientific, 2013). Image generated using JADE Pro (MDI, 2024).

Figure 4

Figure 5. Comparison of the experimental powder pattern of niraparib tosylate monohydrate reported by Wu et al. (2023) (green) with that calculated from the single-crystal structure of Mudda et al. (2024) (black). The literature pattern (measured using Cu Kα radiation) was digitized using UN-SCAN-IT (Silk Scientific, 2013). Image generated using JADE Pro (MDI, 2024).

Figure 5

TABLE I. Lattice parameters of niraparib tosylate monohydrate. Space group P-1

Figure 6

Figure 6. Comparison of the experimental synchrotron powder pattern of niraparib tosylate monohydrate Form I (298 K; black) with that calculated from the single-crystal structure of Mudda et al. (2024) (100 K; black) (calculated using the synchrotron wavelength of 0.819563(2) Å). Image generated using JADE Pro (MDI, 2024).

Figure 7

Figure 7. Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of niraparib tosylate monohydrate Form I. The root-mean-square Cartesian displacements for the cation and the anion are 0.117 and 0.109 Å, respectively. Image generated using Mercury (Macrae et al., 2020).

Figure 8

Figure 8. The asymmetric unit of niraparib tosylate monohydrate Form I, with the atom numbering. The atoms are represented by 50% probability spheroids. Image generated using Mercury (Macrae et al., 2020).

Figure 9

Figure 9. The crystal structure of niraparib tosylate monohydrate Form I, viewed down the a-axis. Image generated using Diamond (Crystal Impact, 2023).

Figure 10

TABLE II. Hydrogen bonds (CRYSTAL23) in the crystal structure of niraparib tosylate monohydrate. * = intramolecular.

Figure 11

Figure 10. The hydrogen-bonded clusters of niraparib cations, tosylate anions, and water molecules. Image generated using Mercury (Macrae et al., 2020).

Figure 12

Figure 11. The complex hydrogen-bonded chains along the b-axis in niraparib tosylate monohydrate Form I. Image generated using Mercury (Macrae et al., 2020).